Selective Immunosuppression Targeting the NLRP3 Inflammasome Mitigates the Foreign Body Response to Implanted Biomaterials While Preserving Angiogenesis.
- Resource Type
- Article
- Source
- Advanced Healthcare Materials; 12/27/2023, Vol. 12 Issue 32, p1-15, 15p
- Subject
- Language
- ISSN
- 21922640